Menu
Back to User profile » Dr Yi-Qun Che
Papers published by Dr Yi-Qun Che:
Serum KLKB1 as a Potential Prognostic Biomarker for Hepatocellular Carcinoma Based on Data-Independent Acquisition and Parallel Reaction Monitoring
Che YQ, Zhang Y, Li HB, Shen D, Cui W
Journal of Hepatocellular Carcinoma 2021, 8:1241-1252
Published Date: 12 October 2021
CD24 Contributes to Treatment Effect in ABC-DLBCL Patients with R-CHOP Resistance
Qiao LY, Li HB, Zhang Y, Shen D, Liu P, Che YQ
Pharmacogenomics and Personalized Medicine 2021, 14:591-599
Published Date: 25 May 2021
Serum lncRNAs (CCAT2, LINC01133, LINC00511) with Squamous Cell Carcinoma Antigen Panel as Novel Non-Invasive Biomarkers for Detection of Cervical Squamous Carcinoma
Wang WJ, Wang D, Zhao M, Sun XJ, Li Y, Lin H, Che YQ, Huang CZ
Cancer Management and Research 2020, 12:9495-9502
Published Date: 1 October 2020
Depth of Response and Early Tumor Shrinkage for Predicting Clinical Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab
Che YQ, Zhang Y, Ou KP, Wang D, Shen D, Liu HY, Luo Y
Cancer Management and Research 2020, 12:8527-8534
Published Date: 16 September 2020
Eradication of Hepatitis C Virus (HCV) Improves Survival of Hepatocellular Carcinoma Patients with Active HCV Infection – A Real-World Cohort Study
Luo Y, Zhang Y, Wang D, Shen D, Che YQ
Cancer Management and Research 2020, 12:5323-5330
Published Date: 2 July 2020
Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab
Che YQ, Zhang Y, Wang D, Liu HY, Shen D, Luo Y
Drug Design, Development and Therapy 2019, 13:3727-3734
Published Date: 29 October 2019